Read the original article source of this excerpt.
BBC on 10/21/2020 by Natalie Sherman
The maker of OxyContin painkillers has reached an $8.3bn (£6.3bn) settlement and agreed to plead guilty to criminal charges to resolve a probe of its role in fuelling America’s opioid crisis.
Purdue Pharma will admit to enabling the supply of drugs “without legitimate medical purpose”.
The deal with US Department of Justice resolves some of the most serious claims against the firm.
But it still faces thousands of cases brought by states and families.
Purdue called the deal an “essential” step to wider resolution of the matter.
“Purdue deeply regrets and accepts responsibility for the misconduct detailed by the Department of Justice,” said Steve Miller, who joined Purdue’s board as chairman in July 2018, shortly before the firm sought protection from the litigation by filing for bankruptcy.